Hofseth Biocare ASA: Proxy Rights at Extraordinary General Meeting

Roger Hofseth, Chairman of the Board of Hofseth BioCare ASA, has in connection to the upcoming Extraordinary General Meeting today 20 September 2016, received proxy rights from shareholders representing 66 670 905 shares in the company, equal to 54.55 per cent of the voting rights.
 
Roger Hofseth owns as per the registration date for the EGM a total of 24 831 109 shares, equal to 20.32 per cent of the outstanding shares in the company. 20 981 109 shares are owned via his fully owned company, Roger Hofseth AS, and 3 850 000 shares via a forward contract.
 
After the receipt of the above-mentioned proxies, Mr. Hofseth represents a total of 91 502 014 shares, equal to 74.87 per cent of the voting rights at the Extraordinary General meeting in Hofseth BioCare ASA.
 
Also, reference is made to the notification of 30 August 2016 for convening the EGM in Hofseth BioCare ASA on 20 September 2016. Attached report on share capital increase (in Norwegian), dated 20 September 2016 for the conversion of debt to equity, issued by EY.
 
For further information, please contact:
Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
 
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
EY report on share capital increase